VolitionRx held annual shareholder meeting; 4,261,161 shares represented by proxy or in person
VNRX•Annual meeting results
VolitionRx held its annual shareholder meeting on July 17, 2026.
- Shareholders backed a charter amendment cutting authorized common shares to 150,000,000 from 325,000,000; the amendment was filed and took effect.
- Sadler, Gibb & Associates was ratified as independent auditor for the year ending Dec. 31, 2026.
- A 2026 Stock Incentive Plan was adopted.
